Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astoria Financial Corp stock logo
AF
Astoria Financial
$21.50
$0.00
$14.11
$21.90
N/AN/A1.11 million shsN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
C$0.00
C$3.16
C$4.38
C$244.19MN/A214,990 shs82,983 shs
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
$0.70
$0.54
$2.35
$13.77M2.12190,529 shs26,947 shs
VGO
53693 (VGO.V)
C$0.89
+20.3%
C$0.89
C$0.10
C$0.97
C$64.52MN/A529,371 shs1.66 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astoria Financial Corp stock logo
AF
Astoria Financial
0.00%0.00%0.00%0.00%0.00%
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
0.00%0.00%0.00%0.00%0.00%
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
0.00%0.00%0.00%0.00%0.00%
VGO
53693 (VGO.V)
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Astoria Financial Corp stock logo
AF
Astoria Financial
N/AN/AN/AN/AN/AN/AN/AN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
N/AN/AN/AN/AN/AN/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
VGO
53693 (VGO.V)
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astoria Financial Corp stock logo
AF
Astoria Financial
0.00
N/AN/AN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
0.00
N/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
0.00
N/AN/AN/A
VGO
53693 (VGO.V)
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astoria Financial Corp stock logo
AF
Astoria Financial
N/AN/AN/AN/AN/AN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
N/AN/AN/AN/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
$130.43M0.00N/AN/A($4.69) per share0.00
VGO
53693 (VGO.V)
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astoria Financial Corp stock logo
AF
Astoria Financial
N/A$0.5439.81N/AN/AN/AN/AN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
-$108.33MN/A0.00N/AN/A-79.43%N/A-26.13%N/A
VGO
53693 (VGO.V)
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Astoria Financial Corp stock logo
AF
Astoria Financial
$0.160.74%N/A29.63%N/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
C$0.092.24%N/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
N/AN/AN/AN/AN/A
VGO
53693 (VGO.V)
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astoria Financial Corp stock logo
AF
Astoria Financial
N/AN/AN/A
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
N/AN/AN/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
N/A
0.24
0.21
VGO
53693 (VGO.V)
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Astoria Financial Corp stock logo
AF
Astoria Financial
83.63%
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
N/A
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
35.00%
VGO
53693 (VGO.V)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Astoria Financial Corp stock logo
AF
Astoria Financial
N/AN/AN/ANot Optionable
Imvescor Restaurant Group Inc stock logo
IRG
Imvescor Restaurant Group
147,00060.90 millionN/ANot Optionable
Novelion Therapeutics Inc. stock logo
NVLN
Novelion Therapeutics
10919.62 millionN/AOptionable
VGO
53693 (VGO.V)
147,00072.50 millionN/ANot Optionable

Recent News About These Companies

Cheap Flights from Casablanca Mohamed V. to Vigo
Convert Euro To Egyptian Pound
VIGO Photonics SA VGO
Cheap Vigo to Netherlands flights
Cheap Flights from Belfast to Vigo
VIGO Photonics S.A.
Avis Ford
Vigo Airport, Vigo, Spain [ VGO / LEVX ]
Cheap Vigo to Tunisia flights
Cheap Vigo to Spain flights
Cheap Flights from Beirut to Vigo
Bill Luke Chrysler Jeep Dodge RAM
Cheap Flights from Dublin to Vigo
Cheap Flights from Teesside International to Vigo
Flight time from Vigo to Luton
Underground microbes may have swarmed ancient Mars

Top Headlines

View All Headlines
Astoria Financial stock logo

Astoria Financial NYSE:AF

Astoria Financial Corporation is a unitary savings and loan holding company. The Company's principal business is the operation of its subsidiary, Astoria Bank. Astoria Bank's primary business is attracting retail deposits from the general public and businesses and investing those deposits, together with funds generated from operations, principal repayments on loans and securities and borrowings, primarily in multi-family and commercial real estate mortgage loans, one- to four-family, or residential, mortgage loans and mortgage-backed securities. Astoria Bank also invests in consumer and other loans, the United States Government, government agency and government-sponsored enterprise (GSE) securities, and other investments permitted by federal banking laws and regulations. Its loan portfolio consists primarily of mortgage loans, and consumer and other loans. The Company's investment activities include securities available-for-sale and securities held-to-maturity.

Imvescor Restaurant Group stock logo

Imvescor Restaurant Group TSE:IRG

Imvescor Restaurant Group Inc is a Canada-based franchise and licensing company. Its operating segments are Franchising, Manufacturing and Corporate. The Franchising segment comprises franchising royalties, supplier contributions and franchise fees from the Company's franchised restaurant brands, as well as retail royalties from the sales of branded products to retailers. The Manufacturing segment is engaged in manufacture and sale of ingredients and prepared food to franchised and Company-owned restaurants, distributors and retailers. The Corporate segment provides administrative and support functions to those operating segments. It operates approximately four restaurant brands in Eastern Canada, which include Pizza Delight, Trattoria di Mikes, Scores and Baton Rouge, and licenses to third parties the right to manufacture and sell prepared food products. It also manufactures and sells vegetarian branded food products in grocery stores and retail outlets under the Commensal brand.

Novelion Therapeutics stock logo

Novelion Therapeutics NASDAQ:NVLN

Novelion Therapeutics Inc., a biopharmaceutical company, develops a portfolio of therapies for individuals living with rare diseases in the United States, Brazil, and internationally. The company's commercial products include lomitapide hard capsule for the treatment of homozygous familial hypercholesterolemia in adults under the JUXTAPID and LOJUXTA brands; and metreleptin, a recombinant analogue of human leptin, which is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy under the MYALEPT brand. Its orphan drug-designated product candidate is zuretinol acetate, an oral synthetic retinoid, which is in development for the treatment of inherited retinal disease caused by underlying mutations in retinal pigment epithelium protein 65 and lecithin: retinol acyltransferase genes. The company was formerly known as QLT Inc. and changed its name to Novelion Therapeutics Inc. in November 2016. Novelion Therapeutics Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

53693 (VGO.V) CVE:VGO

C$0.89 +0.15 (+20.27%)
As of 01/18/2018

Vogogo Inc., formerly Southtech Capital Corporation, is a risk management and electronic payment services company. The Company develops software that administers various electronic payments, including card payments, pre-authorized debit, peer-to-peer and online banking payments for the United States, the United Kingdom and Canadian markets. It has presence in Canada. It offers risk mitigation services, including know-your-customer (KYC) profiling and on-boarding, client underwriting, fraud mitigation, real time transaction monitoring, and smart transaction routing, coupled with compliance-based services, such as reporting, sanction checks and anti-money laundering-counter terrorist financing (AML-CTF) processes. It also offers a range of payment services that can be sold separately or bundled together with its risk management services. It operates in compliance as a Canadian Money Service Business with the Financial Transactions and Reports Analysis Centre of Canada (FINTRAC).